NEW YORK (GenomeWeb) – Editas Medicine has announced a three-year collaboration with Italy's Fondazione Telethon and Ospedale San Raffaele to research and develop gene-edited hematopoietic stem cell and T-cell therapies.

Under the terms of the agreement, Editas will collaborate with the Milan-based San Raffaele Telethon Institute for Gene Therapy, a joint project of the two Italian partners. The collaborators will try to develop gene-editing approaches to treat rare diseases, including unspecified indications in blood and bone marrow.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.

May
08
Sponsored by
Dovetail Genomics

This webinar will discuss a proximity ligation-based method for studying structural variation in formalin-fixed paraffin-embedded (FFPE) tissue.